article thumbnail

The potential of AI in pharma R&D

Pharmaceutical Technology

Clinical trial monitoring Completing clinical studies more quickly can mean critical medicines and treatments reach patients faster. What are the potential benefits of using AI in pharma R&D? Bringing a new medicine to market can cost millions or even billions of dollars over years of research and trials.

article thumbnail

EFPIA states AI rules must “enable not hinder” pharma R&D

Drug Discovery World

In a statement, the EFPIA said AI will have an ever more critical role in the research, development and manufacturing of medicinal products, allowing the discovery, development and delivery of new, safer, more effective treatments to patients faster than ever before.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D

BioTech 365

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D ? Quantum computing offers the potential to significantly accelerate and optimize the discovery of future new medicines for patients ?

article thumbnail

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D

The Pharma Data

However, we are convinced that this technology could help us to provide even more humans and animals with innovative and groundbreaking medicines in the future.”. Quantum computing is still very much an emerging technology.